Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

  • 1 June 2006
    • journal article
    • practice guideline
    • Vol. 47  (6) , 1059-66
Abstract
No abstract available

This publication has 0 references indexed in Scilit: